Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 36 Issue 2
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2018  >  36(2): 147-155

FENG Shuang, HU Ming. Cost-effectiveness analysis of Danshenchuanxiongqin injection vs salvianolate injection for angina pectoris[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 147-155. doi: 10.3969/j.issn.1006-0111.2018.02.011
Citation: FENG Shuang, HU Ming. Cost-effectiveness analysis of Danshenchuanxiongqin injection vs salvianolate injection for angina pectoris[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 147-155. doi: 10.3969/j.issn.1006-0111.2018.02.011
shu

Cost-effectiveness analysis of Danshenchuanxiongqin injection vs salvianolate injection for angina pectoris

doi: 10.3969/j.issn.1006-0111.2018.02.011

  • West China School of Pharmacy, Sichuan University, Sichuan Chengdu 610041, China

  • Received Date: 2017-08-03
  • Rev Recd Date: 2017-10-23
  • Objective To compare the cost-effectiveness of Danshenchuanxiongqin injection versus salvianolate injection for angina pectoris. Methods Databases including CBM, CNKI, VIP, Cochrane library, Pubmed, Embase and Wanfang were electronically searched for the randomized controlled trials (RCTs) on the comparison between Danshen Chuanxiongqin injection and Dsnshenduofensuanyan injection. Literatures were screened and data were extracted in accordance with the inclusion and exclusion criteria. Clinical efficacy of the two drugs were obtained through indirect Meta-analysis. Economic evaluation was carried out using the cost-effectiveness analysis, direct medical cost data included the cost of conventional treatment, drug, examination and hospital expenses. Results Through indirect Meta-analysis, the improvement efficiency of angina were 89.51% and 92.52% for Danshenchuanxiongqin injection and salvianolate injection. The success rates of ECG were 81.40% and 84.05% for two drugs. The costs of Danshenchuanxiognqin injection and salvianolate injection were 4099.71 and 5410.16 CNY. The Cost-effectiveness ratio of angina improve of two drugs were 45.80 and 58.48, while the ECG improve were 50.36 and 64.37. And the sensitivity analysis results were stable. Conclusion Compared to salvianolate injection, salvianolate injection was probably cost-effective for angina pectoris.
  • [1] 吴长艳. 冠心病心绞痛中西医联合治疗方法的研究进展[J]. 中国城乡企业卫生.2014,4(2):19-20.
    [2] 刘拥军, 杨武军. 丹参川芎嗪用于冠心病心绞痛治疗60例临床分析[J]. 航空航天医学杂志,2013,24(2):200-201.
    [3] 陈夏. 丹参多酚酸盐治疗冠心病心绞痛的临床分析[J]. 医学信息,2013, (22):455-456.
    [4] 肖洁,胡明.丹参川芎嗪注射液对比丹参多酚酸盐注射液治疗脑梗死的临床疗效及药物经济学评价[J].中国循证心血管医学杂志,2016,8(10):1171-1176
    [5] 蔡莉莉,李德梅,李敬会,等. 合贝爽联合丹参川芎嗪注射液治疗老年不稳定性心绞痛的疗效及安全性评价[J]. 中国老年保健医学,2013,11(6):14-16
    [6] 程文栋. 丹参多酚酸盐治疗冠心病心绞痛临床疗效观察[J]. 现代预防医学,2010,37(22):4386-4387.
    [7] 吕业. 用丹参多酚酸盐治疗冠心病心绞痛的疗效与安全性评价[J]. 中国现代药物应用,2013,7(13):109-110.
    [8] 黄华文, 周宏霞, 朱兰惠. 丹参多酚酸盐合并硝酸异山梨酯治疗冠心病35例疗效观察[J]. 广东医学院学报,2012,30(2):167-168.
    [9] 巩亮, 姜黔峰, 赵鸿彦,等. 丹参多酚酸盐治疗冠心病心绞痛患者60例[J]. 中国老年学杂志,2012,32(16):3517-3518.
    [10] 刘湘玲. 注射用丹参多酚酸盐治疗冠心病心绞痛疗效观察[J]. 中国中医急症,2009,18(8):1213-1215.
    [11] 杨溶海, 方长庚, 梁建光. 丹参多酚酸盐对冠心病心力衰竭患者左心功能及血清心型脂肪酸结合蛋白的影响[J]. 中国老年学杂志,2014,34(9):2323-2325.
    [12] 黄鸿博, 王海霞, 胡征. 丹参多酚酸盐对冠心病PCI患者术后血液流变学及心功能的影响[J]. 心脑血管病防治,2014,14(3):225-227.
    [13] 刘新成. 丹参多酚酸盐治疗冠心病心绞痛的疗效观察[J]. 中国保健营养,2014(10):610-611
    [14] 卢结文. 丹参多酚酸盐治疗冠心病心绞痛68例[J]. 环球中医药,2009,2(4):278-279.
    [15] 戴书勇, 霍勇, 黄博. 硝酸甘油联合丹参川芎嗪治疗心绞痛的有效性和安全性分析[J]. 航空航天医学杂志,2014,25(3):361-362.
    [16] 赖日辉, 黄志尧. 丹参川芎嗪治疗糖尿病合并冠心病的临床疗效[J]. 中国医药指南,2012,10(33):613-614.
    [17] 李耕石, 梁君, 蒋岩松,等丹参川芎嗪注射液治疗心绞痛100例临床观察[J]. 中外医疗,2009,28(36):100.
    [18] 王晓, 连慧丽. 丹参川芎嗪注射液治疗冠心病心绞痛疗效观察[J]. 中国民康医学,2010,22(10):1257,1312.
    [19] 马存莲, 曲培向, 李拉秀. 丹参川芎嗪注射液治疗80例冠心病心绞痛疗效观察[J]. 中国保健营养(中旬刊),2013(1):213-213.
    [20] 王绍英. 丹参川芎嗪注射液治疗冠心病心绞痛60例疗效观察[J]. 吉林医学,2012,33(34):7485-7486.
    [21] 伍泠露. 丹参川穹嗪注射液治疗冠心病心绞痛的疗效[J]. 医学临床研究,2009,26(6):1090-1091.
    [22] 熊斌, 王鹏. 丹参川芎嗪注射液治疗冠心病心绞痛85例疗效观察[J]. 西北药学杂志,2009,24(4):300-301.
    [23] 徐国良, 秦玲. 丹参川芎嗪注射液治疗冠心病心绞痛临床观察[J].中国中医急症,2012,21(4):614-615.
    [24] 袁玉环, 赵文兵.中西医结合治疗冠心病心绞痛67例[J]. 中国民间疗法,2013,21(1):58-59.
    [25] 赵文强. 硝酸甘油联合丹参川芎嗪治疗心绞痛40例[J]. 中国药业,2013,22(4):79-80.
    [26] 石维伶. 丹参多酚酸盐对冠心病心绞痛患者疗效及凝血指标的影响[J]. 临床医学研究与实践,2017,2(9):30-31.
    [27] 郭晓欣,廖欢,李成斌. 丹参多酚酸盐治疗冠心病心绞痛的效果分析与研究[J]. 健康前沿,2017,26(2):199.
    [28] 邝洁瑜,肖美颜. 丹参多酚酸盐治疗冠心病心绞痛疗效的初步观察及评估[J]. 临床医学工程,2017,24(4):497-498.
    [29] 陈信. 注射用丹参多酚酸盐治疗冠心病患者的疗效[J]. 医疗装备,2017,30(2):83-84.
    [30] 饶国华,洗立维. 注射用丹参多酚酸盐治疗冠心病心绞痛的疗效观察[J],海峡药学.2015,27(5):136-138.
    [31] 迟永生. 丹参多酚酸盐治疗冠心病心绞痛的疗效观察[J]. 中国高等医学教育,2016,(7). 136-137.
    [32] 薛梅苓,冯琴琴. 丹参多酚酸盐治疗心血瘀阻型冠心病心绞痛临床疗效及安全性研究[J]. 中国药业,2016,25(18):31-34.
    [33] 周晓瑛. 丹参多酚酸盐注射治疗稳定性心绞痛的效果[J]. 今日健康,2016,15(10):167.
    [34] 陈灏璟,张睿,龚和禾. 美托洛尔联合丹参多酚酸盐对老年冠心病心绞痛病人血脂、超敏C-反应蛋白的影响[J]. 中西医结合心脑血管病杂志,2016,14(3):250-253.
    [35] 李洪涛. 注射用丹参多酚酸盐治疗冠心病心绞痛的临床效果观察[J]. 中国处方药,2016,14(9):85-86.
    [36] 朱世国,杨继东. 注射用丹参多酚酸盐治疗老年冠心病心绞痛临床观察[J]. 中国民族民间医药,2016,25(22):87-89.
    [37] 周坤,王梅. 丹参多酚酸盐对老年冠心病心绞痛患者血清VEGF、MMP-9的影响[J]. 临床合理用药杂志,2015,8(2):1-3.
    [38] 何琳,栗世婷. 探究丹参川芎嗪注射液对冠心病心绞痛的疗效[J]. 中西医结合心血管病电子杂志,2017,5(1):74-75.
    [39] 王绍杰,周经科. 丹参川芎嗪注射液治疗冠心病心绞痛的价值评价[J]. 中国现代药物应用,2015,9(10):20-21.
    [40] 李庆. 探讨丹参川芎嗪注射液治疗108例冠心病心绞痛患者的疗效[J]. 中西医结合心血管病电子杂志,2015,3(1):79-80.
    [41] 双莲. 丹参川芎嗪注射液治疗冠心病心绞痛疗效观察[J]. 转化医学电子杂志,2015,2(10):75-78.
    [42] 盛潇磊. 老年冠心病心绞痛患者应用丹参川芎嗪注射液的临床意义分析[J]. 医学信息,2015,28(49):297-297.
    [43] 丁玉峰, 吴方建. 药物经济学理论及应用[J].中国药师,2004,7(7):507-510.
    [44] 刘国恩, 张玉哲, 范丽亚, 等. 急性缺血性脑卒中三种常用神经保护药物成本-效果分析[J].中国卫生经济,2012,8(31):62-65.
    [45] 马爱霞, 李洪超, 马骏捷, 等. 醒脑静注射液和依达拉奉治疗急性缺血性脑卒中的成本效果分析[J].中国药物评价,2013,30(3):173-177.
    [46] 伍红艳.贵阳市居民对冠心病心绞痛治疗药物支付意愿的调查分析[J]. 中国药房,2015,26(36):5045-5048.
    [47] 王瑜.丹参川芎嗪注射液的临床应用研究进展[J].天津药学,2015,27(4):53-55.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(4303) PDF downloads(641) Cited by()

Related
Proportional views

Cost-effectiveness analysis of Danshenchuanxiongqin injection vs salvianolate injection for angina pectoris

doi: 10.3969/j.issn.1006-0111.2018.02.011
  • West China School of Pharmacy, Sichuan University, Sichuan Chengdu 610041, China
  • Received Date: 2017-08-03
  • Rev Recd Date: 2017-10-23

Abstract: Objective To compare the cost-effectiveness of Danshenchuanxiongqin injection versus salvianolate injection for angina pectoris. Methods Databases including CBM, CNKI, VIP, Cochrane library, Pubmed, Embase and Wanfang were electronically searched for the randomized controlled trials (RCTs) on the comparison between Danshen Chuanxiongqin injection and Dsnshenduofensuanyan injection. Literatures were screened and data were extracted in accordance with the inclusion and exclusion criteria. Clinical efficacy of the two drugs were obtained through indirect Meta-analysis. Economic evaluation was carried out using the cost-effectiveness analysis, direct medical cost data included the cost of conventional treatment, drug, examination and hospital expenses. Results Through indirect Meta-analysis, the improvement efficiency of angina were 89.51% and 92.52% for Danshenchuanxiongqin injection and salvianolate injection. The success rates of ECG were 81.40% and 84.05% for two drugs. The costs of Danshenchuanxiognqin injection and salvianolate injection were 4099.71 and 5410.16 CNY. The Cost-effectiveness ratio of angina improve of two drugs were 45.80 and 58.48, while the ECG improve were 50.36 and 64.37. And the sensitivity analysis results were stable. Conclusion Compared to salvianolate injection, salvianolate injection was probably cost-effective for angina pectoris.

FENG Shuang, HU Ming. Cost-effectiveness analysis of Danshenchuanxiongqin injection vs salvianolate injection for angina pectoris[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 147-155. doi: 10.3969/j.issn.1006-0111.2018.02.011
Citation: FENG Shuang, HU Ming. Cost-effectiveness analysis of Danshenchuanxiongqin injection vs salvianolate injection for angina pectoris[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 147-155. doi: 10.3969/j.issn.1006-0111.2018.02.011
shu

    HTML

Reference (47)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return